Tanvex BioPharma USA, Inc. announced that it will raise $50 million in a round of funding on February 6, 2024. The transaction will include participation from returning investor, Tanvex BioPharma, Inc. The company will issue common stock in the transaction. The transaction has been approved at the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48 TWD | +1.05% | +4.12% | -26.27% |
1st Jan change | Capi. | |
---|---|---|
-26.27% | 241M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma USA, Inc. announced that it expects to receive $50 million in funding from Tanvex BioPharma, Inc.